Otsuka Holdings Co., Ltd. (OTSKF)
OTCMKTS
· Delayed Price · Currency is USD
47.80
0.00 (0.00%)
Apr 23, 2025, 4:00 PM EDT
Otsuka Holdings Revenue
In the year 2024, Otsuka Holdings had annual revenue of 2.33T JPY with 15.42% growth. Otsuka Holdings had revenue of 599.79B in the quarter ending December 31, 2024, with 11.18% growth.
Revenue
2,329.86B JPY
Revenue Growth
+15.42%
P/S Ratio
1.66
Revenue / Employee
65.93M JPY
Employees
35,338
Market Cap
24.62B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2,329.86B | 311.29B | 15.42% |
Dec 31, 2023 | 2,018.57B | 280.57B | 16.14% |
Dec 31, 2022 | 1,738.00B | 239.72B | 16.00% |
Dec 31, 2021 | 1,498.28B | 75.45B | 5.30% |
Dec 31, 2020 | 1,422.83B | 26.59B | 1.90% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
SS Innovations International | 20.65M |
Veradigm | 588.02M |
Northwest Biotherapeutics | 1.38M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 200.90M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |